NMS-P118 - 97%, high purity , CAS No.1262417-51-5

Item Number

N413987

• Synonyms: 1H-Isoindole-4-carboxamide, 2-(1-(4,4-difluorocyclohexyl)-4-piperidinyl)-6-fluoro-2,3-dihydro-3-oxo- | AT32155 | CS-6144 | EX-A1271 | 2-[1-(4,4-Difluorocyclohexyl)-piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide | 2-[1-(4,4-difluoroc
• Specifications & Purity: ≥97%
• Biochemical and Physiological Mechanisms: NMS-P118 is a potent, orally available, and highly selective PARP-1 inhibitor endowed with excellent ADME and pharmacokinetic profiles, showing 150-fold selectivity for PARP-1 over PARP-2 (Kd 0.009 μM vs 1.39 μM, respectively).
• Storage Temp: Store at -20°C
• Shipped In: Ice chest + Ice pads

Product Description

Information

NMS-P118 is a potent, orally available, and highly selectivePARP-1inhibitor endowed with excellent ADME and pharmacokinetic profiles, showing 150-fold selectivity for PARP-1 over PARP-2 (Kd 0.009 μM vs 1.39 μM, respectively).

Targets

PARP1 (Cell-free assay) 0.009 μM(Kd)

In vitro

NMS-P118 is a potent (KD = 0.009 μM) PARP-1 inhibitor, showing 150-fold selectivity over PARP-2 (KD = 1.39 μM). The compound shows high solubility and permeability.

In vivo

NMS-P118 is proved to be metabolically stable, it modestly inhibits two cytochrome P450 family members (CYP-2B6 IC50, 8.15 μM; CYP-2D6 IC50, 9.51 μM) out of eight isoforms tested. NMS-P118 has low in vivo clearance, and complete oral bioavailability. The pharmacokinetic profile of NMS-P118 in rat dosed iv at 10 mg/kg and orally at 10 and 100 mg/kg, mirrors that observed in the mouse, with oral bioavailability >65%, and linearity of exposure with dose. Its treatment dramatically decreases intratumoral PAR levels at 1, 2, and 6 h after administration and partial recovery of PAR levels is observed at 24 h. NMS-P118 shows excellent ADME and pharmacokinetic profiles, high oral availability in the mouse and rat, and high efficacy both as a single agent and in combination with Temozolomide in BRCA1-mutated MDA-MB-436 and BRCA2 deficient Capan-1 human tumor xenograft models, respectively.

Cell Research(from reference)

Cell lines：HeLa cells 

Incubation Time：30 mins